Harald Holte
Harald Holte
Oslo University Hospital
Geverifieerd e-mailadres voor ous-hf.no
Geciteerd door
Geciteerd door
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald, G Wright, WC Chan, JM Connors, E Campo, RI Fisher, ...
New England Journal of Medicine 346 (25), 1937-1947, 2002
A prognostic score for advanced Hodgkin's disease
D Hasenclever, V Diehl, JO Armitage, D Assouline, M Björkholm, ...
New England Journal of Medicine 339 (21), 1506-1514, 1998
Stromal gene signatures in large-B-cell lymphomas
G Lenz, G Wright, SS Dave, W Xiao, J Powell, H Zhao, W Xu, B Tan, ...
New England Journal of Medicine 359 (22), 2313-2323, 2008
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave, G Wright, B Tan, A Rosenwald, RD Gascoyne, WC Chan, ...
New England Journal of Medicine 351 (21), 2159-2169, 2004
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald, G Wright, K Leroy, X Yu, P Gaulard, RD Gascoyne, ...
The Journal of experimental medicine 198 (6), 851-862, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald, G Wright, A Wiestner, WC Chan, JM Connors, E Campo, ...
Cancer cell 3 (2), 185-197, 2003
Molecular diagnosis of Burkitt's lymphoma
SS Dave, K Fu, GW Wright, LT Lam, P Kluin, EJ Boerma, TC Greiner, ...
New England Journal of Medicine 354 (23), 2431-2442, 2006
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a …
MHJ Van Oers, R Klasa, RE Marcus, M Wolf, E Kimby, RD Gascoyne, ...
Blood 108 (10), 3295-3301, 2006
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
S Bea, A Zettl, G Wright, I Salaverria, P Jehn, V Moreno, C Burek, G Ott, ...
Blood 106 (9), 3183-3190, 2005
Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma
SJ Schuster, MR Bishop, CS Tam, EK Waller, P Borchmann, JP McGuirk, ...
New England Journal of Medicine 380 (1), 45-56, 2019
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01
F d'Amore, T Relander, GF Lauritzsen, E Jantunen, H Hagberg, ...
Journal of Clinical Oncology 30 (25), 3093-3099, 2012
Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study
MHJ Van Oers, M Van Glabbeke, L Giurgea, R Klasa, RE Marcus, M Wolf, ...
Journal of Clinical Oncology 28 (17), 2853, 2010
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
DD Weisenburger, KJ Savage, NL Harris, RD Gascoyne, ES Jaffe, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3402-3408, 2011
Central nervous system involvement following diagnosis of non-Hodgkin’s lymphoma: a risk model
A Hollender, S Kvaloy, O Nome, E Skovlund, K Lote, H Holte
Annals of Oncology 13 (7), 1099-1107, 2002
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
J Bergh, T Wiklund, B Erikstein, E Lidbrink, H Lindman, P Malmström, ...
The Lancet 356 (9239), 1384-1391, 2000
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
J Delabie, H Holte, JM Vose, F Ullrich, ES Jaffe, KJ Savage, JM Connors, ...
Blood, The Journal of the American Society of Hematology 118 (1), 148-155, 2011
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
E Osby, H Hagberg, S Kvaløy, L Teerenhovi, H Anderson, ...
Blood, The Journal of the American Society of Hematology 101 (10), 3840-3848, 2003
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
A Wiestner, M Tehrani, M Chiorazzi, G Wright, F Gibellini, K Nakayama, ...
Blood, The Journal of the American Society of Hematology 109 (11), 4599-4606, 2007
A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation
MJ Hjermstad, H Knobel, L Brinch, PM Fayers, JH Loge, H Holte, S Kaasa
Bone marrow transplantation 34 (3), 257-266, 2004
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas
AK Blystad, G Enblad, S Kvaløy, Å Berglund, J Delabie, H Holte, ...
Bone marrow transplantation 27 (7), 711-716, 2001
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20